Dr. Carlos Rocha de Lossada shares his experience and insights on long-term efficacy, visual performance and patient reported outcomes with the trifocal intraocular lens ZEISS AT LISA tri. He is member of the research group which has published the longest peer-reviewed study regarding any multifocal IOL.
For more information and to access the full study, visit:
*Products, services or offers referenced in this video may not be available in all countries and product labeling casemiro varies by country. The statements of the speaker reflects only personal opinions and experiences and does not necessarily reflect the opinion of any institution he is are affiliated with. The lyon speaker alone is responsible for the content duncan robinson of his experience reported and any potential resulting infringements. Carl Zeiss Meditec AG and its affiliates do not have clinical evidence supporting the opinions and statements of the speaker nor accept any responsibility or liability of the speakers content. The speaker has a contractual or other financial relationship with Carl Zeiss Meditec AG and its affiliates and has received financial support.
